Showing 3681-3690 of 4063 results for "".
- Health Canada Authorizes Enspryng for Canadians Living with Neuromyelitis Optica Spectrum Disorderhttps://modernod.com/news/health-canada-authorizes-enspryng-for-canadians-living-with-neuromyelitis-optica-spectrum-disorder/2478219/Roche Canada announced that Health Canada has granted market authorization for Enspryng (satralizumab) as monotherapy or in combination with immunosuppressive therapy (IST) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult and adolescent patients who are anti-aqu
- Studies Evaluate Effectiveness of Intracameral Omidria for Reducing Postoperative CMEhttps://modernod.com/news/studies-evaluate-effectiveness-of-intracameral-omidria-for-reducing-postoperative-cme/2478216/Recent studies evaluating the use of Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3% for the reduction of postoperative clinical cystoid macular edema (CME) incidence show the drug to be safe and effective. Omidria was commercially launched in the US in 2015 as the first
- Prevent Blindness to Kick Off Virtual Persons of Vision Award Event Honoring VSP Globalhttps://modernod.com/news/prevent-blindness-to-kick-off-virtual-persons-of-vision-award-event-honoring-vsp-global/2478212/Prevent Blindness announced that the 2020 Persons of Vision Award ceremony, honoring VSP Global, will be held through a series of virtual celebrations in September. The Prevent Blindness Persons of Vision Award recognizes an individual, corporation and/or organization whose inspired outloo
- Clearside Biomedical Expands Patent Portfolio in the US and Europehttps://modernod.com/news/clearside-biomedical-expands-patent-portfolio-in-the-us-and-europe/2478203/Clearside Biomedical announced the recent issuance of three additional patents in the United States and Europe. The United States Patent and Trademark Office (USPTO) recently granted patent number 10,722,396 to Clearside. This patent covers Clearside’s SCS M
- Alcon Kicks Off Global Social Media Campaignhttps://modernod.com/news/alcon-kicks-off-global-social-media-campaign/2478183/Alcon kicked off a global social media campaign, “Reasons to Love Lenses,” during Contact Lens Health Week taking place August 17–21. The new campaign raises consumer awareness of the benefits of contact lens wear. The campaign also reiterates the value of prescribing contact lenses for eye care
- LensGen Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directorshttps://modernod.com/news/lensgen-closes-10-million-financing-and-welcomes-james-v-mazzo-to-its-board-of-directors/2478182/LensGen announced the initial closing of a $10 million of the $20 million Bridge Financing and announcd the election of James Mazzo to its Board of Directors.
- Nearly Half of Physicians Believe It Will Take a Year to Get COVID-19 Under Controlhttps://modernod.com/news/nearly-half-of-physicians-believe-it-will-take-a-year-to-get-covid-19-under-control/2478174/The majority of physicians believe COVID-19 won’t be under control until January 2021, and nearly half (49%) expect it will take much longer to get the virus under control, according to a FierceHealthcare
- Johnson & Johnson Vision Launches Tecnis Synergy and Tecnis Eyhance IOLs in Canadahttps://modernod.com/news/johnson-johnson-vision-launches-tecnis-synergy-and-tecnis-eyhance-iols-in-canada/2478160/Johnson & Johnson Vision announced Health Canada approval and July availability of its Tecnis Synergy and Tecnis Eyhance IOLs to the Canadian market. The Tecnis Synergy, originally launched in Europe in September 2019, delivers continuous high-cont
- BVI Partners With HVO to Provide PPE for Healthcare Workershttps://modernod.com/news/bvi-partners-with-hvo-to-provide-ppe-for-healthcare-workers/2478155/BVI has partnered with Haywood Vocational Opportunities (HVO) to provide isolation gowns to US healthcare workers on the front lines of the pandemic effort. HVO is a US based medical product manufacturer who provides vocational training and employment opportunities for adults with disadva
- Alcon Canada introduces PRECISION1 Contact Lenseshttps://modernod.com/news/alcon-canada-introduces-precision1-contact-lenses/2478144/Alcon has launched the PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses in Canada. Designed to address the common issues that cause 1-in-5 new wearers to discontinue contact lens within the first year (poor vision, comfort and handling issues1), Precision1 he